Selected research
Industry Research
Short Acting Contraceptives Industry Research Report 2026
Market perspective
The global Short Acting Contraceptives market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Short Acting Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Short Acting Contraceptives is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Short Acting Contraceptives is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Short Acting Contraceptives include Bayer AG, China Resources Zizhu Pharmaceutical, Wyeth, Organon, Sichuan Chuanda Huaxi and Zhejiang Xianju, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Short Acting Contraceptives market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Short Acting Contraceptives Market by Company
Bayer AG
China Resources Zizhu Pharmaceutical
Wyeth
Organon
Sichuan Chuanda Huaxi
Zhejiang Xianju
Short Acting Contraceptives Segment by Type
21 Tablets/Box
28 Tablets/Box (With Placebo)
Short Acting Contraceptives Segment by Application
Contraception
Hormone Regulation
Others
Short Acting Contraceptives Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Short Acting Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Short Acting Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Short Acting Contraceptives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Short Acting Contraceptives manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Short Acting Contraceptives by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Short Acting Contraceptives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 21 Tablets/Box
- 28 Tablets/Box (With Placebo)
Applications
- Contraception
- Hormone Regulation
- Others
Companies covered
- Bayer AG
- China Resources Zizhu Pharmaceutical
- Wyeth
- Organon
- Sichuan Chuanda Huaxi
- Zhejiang Xianju
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Short Acting Contraceptives Market Size (2021-2032)
- 2.2.2 Global Short Acting Contraceptives Sales (2021-2032)
- 2.2.3 Global Short Acting Contraceptives Market Average Price (2021-2032)
- 2.3 Short Acting Contraceptives by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 21 Tablets/Box
- 2.3.3 28 Tablets/Box (With Placebo)
- 2.4 Short Acting Contraceptives by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Contraception
- 2.4.3 Hormone Regulation
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Short Acting Contraceptives Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Short Acting Contraceptives Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Short Acting Contraceptives Revenue of Manufacturers (2021-2026)
- 3.4 Global Short Acting Contraceptives Average Price by Manufacturers (2021-2026)
- 3.5 Global Short Acting Contraceptives Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Short Acting Contraceptives, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Short Acting Contraceptives, Product Type & Application
- 3.8 Global Manufacturers of Short Acting Contraceptives, Established Date
- 3.9 Global Short Acting Contraceptives Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bayer AG
- 4.1.1 Bayer AG Company Information
- 4.1.2 Bayer AG Business Overview
- 4.1.3 Bayer AG Short Acting Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bayer AG Short Acting Contraceptives Product Portfolio
- 4.1.5 Bayer AG Recent Developments
- 4.2 China Resources Zizhu Pharmaceutical
- 4.2.1 China Resources Zizhu Pharmaceutical Company Information
- 4.2.2 China Resources Zizhu Pharmaceutical Business Overview
- 4.2.3 China Resources Zizhu Pharmaceutical Short Acting Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 China Resources Zizhu Pharmaceutical Short Acting Contraceptives Product Portfolio
- 4.2.5 China Resources Zizhu Pharmaceutical Recent Developments
- 4.3 Wyeth
- 4.3.1 Wyeth Company Information
- 4.3.2 Wyeth Business Overview
- 4.3.3 Wyeth Short Acting Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Wyeth Short Acting Contraceptives Product Portfolio
- 4.3.5 Wyeth Recent Developments
- 4.4 Organon
- 4.4.1 Organon Company Information
- 4.4.2 Organon Business Overview
- 4.4.3 Organon Short Acting Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Organon Short Acting Contraceptives Product Portfolio
- 4.4.5 Organon Recent Developments
- 4.5 Sichuan Chuanda Huaxi
- 4.5.1 Sichuan Chuanda Huaxi Company Information
- 4.5.2 Sichuan Chuanda Huaxi Business Overview
- 4.5.3 Sichuan Chuanda Huaxi Short Acting Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sichuan Chuanda Huaxi Short Acting Contraceptives Product Portfolio
- 4.5.5 Sichuan Chuanda Huaxi Recent Developments
- 4.6 Zhejiang Xianju
- 4.6.1 Zhejiang Xianju Company Information
- 4.6.2 Zhejiang Xianju Business Overview
- 4.6.3 Zhejiang Xianju Short Acting Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Zhejiang Xianju Short Acting Contraceptives Product Portfolio
- 4.6.5 Zhejiang Xianju Recent Developments
5 Global Short Acting Contraceptives Market Scenario by Region
- 5.1 Global Short Acting Contraceptives Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Short Acting Contraceptives Sales by Region: 2021-2032
- 5.2.1 Global Short Acting Contraceptives Sales by Region: 2021-2026
- 5.2.2 Global Short Acting Contraceptives Sales by Region: 2027-2032
- 5.3 Global Short Acting Contraceptives Revenue by Region: 2021-2032
- 5.3.1 Global Short Acting Contraceptives Revenue by Region: 2021-2026
- 5.3.2 Global Short Acting Contraceptives Revenue by Region: 2027-2032
- 5.4 North America Short Acting Contraceptives Market Facts & Figures by Country
- 5.4.1 North America Short Acting Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Short Acting Contraceptives Sales by Country (2021-2032)
- 5.4.3 North America Short Acting Contraceptives Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Short Acting Contraceptives Market Facts & Figures by Country
- 5.5.1 Europe Short Acting Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Short Acting Contraceptives Sales by Country (2021-2032)
- 5.5.3 Europe Short Acting Contraceptives Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Short Acting Contraceptives Market Facts & Figures by Country
- 5.6.1 Asia Pacific Short Acting Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Short Acting Contraceptives Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Short Acting Contraceptives Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Short Acting Contraceptives Market Facts & Figures by Country
- 5.7.1 South America Short Acting Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Short Acting Contraceptives Sales by Country (2021-2032)
- 5.7.3 South America Short Acting Contraceptives Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Short Acting Contraceptives Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Short Acting Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Short Acting Contraceptives Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Short Acting Contraceptives Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Short Acting Contraceptives Sales by Type (2021-2032)
- 6.1.1 Global Short Acting Contraceptives Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Short Acting Contraceptives Sales Market Share by Type (2021-2032)
- 6.2 Global Short Acting Contraceptives Revenue by Type (2021-2032)
- 6.2.1 Global Short Acting Contraceptives Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Short Acting Contraceptives Revenue Market Share by Type (2021-2032)
- 6.3 Global Short Acting Contraceptives Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Short Acting Contraceptives Sales by Application (2021-2032)
- 7.1.1 Global Short Acting Contraceptives Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Short Acting Contraceptives Sales Market Share by Application (2021-2032)
- 7.2 Global Short Acting Contraceptives Revenue by Application (2021-2032)
- 7.2.1 Global Short Acting Contraceptives Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Short Acting Contraceptives Revenue Market Share by Application (2021-2032)
- 7.3 Global Short Acting Contraceptives Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Short Acting Contraceptives Value Chain Analysis
- 8.1.1 Short Acting Contraceptives Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Short Acting Contraceptives Production Mode & Process
- 8.2 Short Acting Contraceptives Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Short Acting Contraceptives Distributors
- 8.2.3 Short Acting Contraceptives Customers
9 Global Short Acting Contraceptives Analyzing Market Dynamics
- 9.1 Short Acting Contraceptives Industry Trends
- 9.2 Short Acting Contraceptives Industry Drivers
- 9.3 Short Acting Contraceptives Industry Opportunities and Challenges
- 9.4 Short Acting Contraceptives Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst